The more aggressive subtypes triple negative breast cancer (TNBC) (41%, 95% CI 38-45%) and HER2+ tumors (54%, 95% CI 43-66%), had increased frequencies of pCR (Figure 3B, 3C). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.